• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合并症与重症 COVID-19 结局:罗马尼亚三个县住院患者的回顾性分析

Comorbidities and Severe COVID-19 Outcomes: A Retrospective Analysis of Hospitalized Patients in Three Counties in Romania.

作者信息

Bodea Réka, Voidăzan Toader Septimiu, Ferencz Lorand Iozsef, Ábrám Zoltán

机构信息

Department of Epidemiology, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mureș, 540142 Târgu Mureș, Romania.

Department of Hygiene, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mureș, 540142 Târgu Mureș, Romania.

出版信息

Microorganisms. 2025 Mar 29;13(4):787. doi: 10.3390/microorganisms13040787.

DOI:10.3390/microorganisms13040787
PMID:40284624
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12029577/
Abstract

The COVID-19 pandemic represents a major global health crisis, with clinical manifestations ranging from asymptomatic infection to fatal outcomes. While all individuals are susceptible, specific populations, particularly those with pre-existing medical conditions, face a heightened risk of severe disease. This study aimed to assess the prevalence of severe COVID-19 among hospitalized patients with comorbidities in the Central Region of Romania, and to analyze the association between these conditions and mortality. We conducted a retrospective cohort study using data from the Corona Forms platform (2020-2022), encompassing hospitalized cases across three Romanian counties. A total of 1458 patients with confirmed SARS-CoV-2 infection and documented comorbidities were included. Demographic characteristics, comorbid conditions, and hospitalization outcomes were analyzed. The overall mortality rate among comorbid patients was 89.3%. Renal, neurologic, hepatic disease, cardiovascular conditions, obesity, type 2 diabetes mellitus, and cerebrovascular accidents are significant risk factors for death outcomes in the SARS-CoV-2-infected study population. The strength of their association varies, with odds ratios ranging from 25.32 to 1. The findings underscore the critical impact of comorbidities on COVID-19 severity and mortality among the Central Romanian population, emphasizing the necessity of targeted clinical interventions and public health strategies to protect high-risk populations.

摘要

新冠疫情是一场重大的全球卫生危机,其临床表现从无症状感染到致命后果不等。虽然所有人都易感染,但特定人群,尤其是那些有基础疾病的人群,面临着更高的重症风险。本研究旨在评估罗马尼亚中部地区合并症住院患者中重症新冠肺炎的患病率,并分析这些疾病与死亡率之间的关联。我们利用来自Corona Forms平台(2020 - 2022年)的数据进行了一项回顾性队列研究,涵盖罗马尼亚三个县的住院病例。总共纳入了1458例确诊感染SARS-CoV-2且有合并症记录的患者。分析了人口统计学特征、合并症情况和住院结局。合并症患者的总体死亡率为89.3%。肾脏疾病、神经系统疾病、肝脏疾病、心血管疾病、肥胖症、2型糖尿病和脑血管意外是SARS-CoV-2感染研究人群死亡结局的重要危险因素。它们之间关联的强度各不相同,比值比范围从25.32到1。研究结果强调了合并症对罗马尼亚中部人群新冠肺炎严重程度和死亡率的关键影响,强调了采取针对性临床干预措施和公共卫生策略以保护高危人群的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9c9/12029577/69e25d741753/microorganisms-13-00787-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9c9/12029577/d8c620fac0fe/microorganisms-13-00787-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9c9/12029577/69e25d741753/microorganisms-13-00787-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9c9/12029577/d8c620fac0fe/microorganisms-13-00787-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9c9/12029577/69e25d741753/microorganisms-13-00787-g002.jpg

相似文献

1
Comorbidities and Severe COVID-19 Outcomes: A Retrospective Analysis of Hospitalized Patients in Three Counties in Romania.合并症与重症 COVID-19 结局:罗马尼亚三个县住院患者的回顾性分析
Microorganisms. 2025 Mar 29;13(4):787. doi: 10.3390/microorganisms13040787.
2
Comparative analysis of C-Reactive protein levels among Non-comorbid, Comorbid, and Multimorbid Hospitalized COVID-19 patients.非合并症、合并症和多重合并症住院COVID-19患者C反应蛋白水平的比较分析。
BMC Infect Dis. 2025 Jan 14;25(1):59. doi: 10.1186/s12879-024-10314-2.
3
Association between body-mass index, patient characteristics, and obesity-related comorbidities among COVID-19 patients: A prospective cohort study.新型冠状病毒肺炎患者的体重指数、患者特征与肥胖相关合并症之间的关联:一项前瞻性队列研究。
Obes Res Clin Pract. 2023 Jan-Feb;17(1):47-57. doi: 10.1016/j.orcp.2022.12.003. Epub 2022 Dec 20.
4
Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study.中国武汉 116 例 COVID-19 住院患者的临床特征:一项以医院为中心、回顾性、观察性研究。
BMC Infect Dis. 2020 Oct 22;20(1):787. doi: 10.1186/s12879-020-05452-2.
5
Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.在加拿大,167500 例 COVID-19 患者中,先前存在的合并症与死亡率和疾病严重程度的关系:一项基于人群的队列研究。
PLoS One. 2021 Oct 5;16(10):e0258154. doi: 10.1371/journal.pone.0258154. eCollection 2021.
6
Demographics, clinical characteristics, and outcomes of 27,256 hospitalized COVID-19 patients in Kermanshah Province, Iran: a retrospective one-year cohort study.伊朗克尔曼沙阿省 27256 例住院 COVID-19 患者的人口统计学、临床特征和结局:一项回顾性一年队列研究。
BMC Infect Dis. 2022 Mar 31;22(1):319. doi: 10.1186/s12879-022-07312-7.
7
The Relationship Between Pre-Pandemic Comorbidities With SARS-CoV-2 Infections and Hospitalizations in Black Versus White Military Service Members: A Retrospective Study.《回顾性研究:大流行前合并症与 SARS-CoV-2 感染及黑人群体与白人群体中住院治疗的关系》。
Mil Med. 2024 Aug 19;189(Suppl 3):814-822. doi: 10.1093/milmed/usae294.
8
Prevalence and Impact of Preexisting Comorbidities on Overall Clinical Outcomes of Hospitalized COVID-19 Patients.COVID-19 住院患者的预先存在的合并症的流行情况及其对总体临床结局的影响。
Biomed Res Int. 2022 Apr 6;2022:2349890. doi: 10.1155/2022/2349890. eCollection 2022.
9
Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS-CoV-2 infection in children and young people: A systematic review and individual patient meta-analysis.哪些儿童和青少年在感染SARS-CoV-2后住院会面临更严重疾病和死亡的更高风险:一项系统综述和个体患者荟萃分析。
EClinicalMedicine. 2022 Feb;44:101287. doi: 10.1016/j.eclinm.2022.101287. Epub 2022 Feb 11.
10
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.

本文引用的文献

1
The clinical features and outcomes of diabetes patients infected with COVID-19: a systematic review and meta-analysis comprising 192,693 patients.2019冠状病毒病感染糖尿病患者的临床特征与转归:一项纳入192,693例患者的系统评价与Meta分析
Front Med (Lausanne). 2025 Jan 29;12:1523139. doi: 10.3389/fmed.2025.1523139. eCollection 2025.
2
COVID-19-related morbidity and mortality in people with multiple long-term conditions: a systematic review and meta-analysis of over 4 million people.COVID-19 相关发病率和死亡率在患有多种长期疾病的人群中:超过 400 万人的系统评价和荟萃分析。
J R Soc Med. 2024 Oct;117(10):336-351. doi: 10.1177/01410768241261507. Epub 2024 Oct 16.
3
Mortality and morbidity in critically ill COVID-19 patients: A systematic review and meta-analysis.
危重症 COVID-19 患者的死亡率和发病率:系统评价和荟萃分析。
J Infect Public Health. 2024 Oct;17(10):102533. doi: 10.1016/j.jiph.2024.102533. Epub 2024 Aug 29.
4
Comparison between high-flow nasal oxygen (HFNO) alternated with non-invasive ventilation (NIV) and HFNO and NIV alone in patients with COVID-19: a retrospective cohort study.高流量鼻氧(HFNO)与无创通气(NIV)交替治疗与 HFNO 和 NIV 单独治疗 COVID-19 患者的比较:一项回顾性队列研究。
Eur J Med Res. 2024 Apr 22;29(1):248. doi: 10.1186/s40001-024-01826-3.
5
Risk factors for COVID-19 hospitalization and mortality in patients with chronic kidney disease: a nationwide cohort study.慢性肾脏病患者新冠病毒肺炎住院及死亡的危险因素:一项全国性队列研究
Clin Kidney J. 2023 Nov 28;17(1):sfad283. doi: 10.1093/ckj/sfad283. eCollection 2024 Jan.
6
The Effect of Comorbidities and Complications on COVID-19 Mortality: A Detailed Retrospective Study in Western Romania.合并症和并发症对新冠肺炎死亡率的影响:罗马尼亚西部的一项详细回顾性研究
J Pers Med. 2023 Oct 29;13(11):1552. doi: 10.3390/jpm13111552.
7
Effects of the pre-existing coronary heart disease on the prognosis of COVID-19 patients: A systematic review and meta-analysis.既往冠心病对 COVID-19 患者预后的影响:系统评价和荟萃分析。
PLoS One. 2023 Oct 10;18(10):e0292021. doi: 10.1371/journal.pone.0292021. eCollection 2023.
8
Comorbidities of COVID-19 Patients.COVID-19 患者的合并症。
Medicina (Kaunas). 2023 Jul 29;59(8):1393. doi: 10.3390/medicina59081393.
9
Comorbidities associated with the severity of COVID-19, and differences across ethnic groups: a UK Biobank cohort study.与 COVID-19 严重程度相关的合并症,以及不同种族群体之间的差异:英国生物银行队列研究。
BMC Public Health. 2023 Aug 17;23(1):1566. doi: 10.1186/s12889-023-16499-6.
10
Emergence of COVID-19 Variants: An Update.新型冠状病毒肺炎变异株的出现:最新情况
Cureus. 2023 Jul 3;15(7):e41295. doi: 10.7759/cureus.41295. eCollection 2023 Jul.